/ CompletedNot Applicable A open label, balanced, randomized, single center, two treatment, two period, two sequence, two-way, controlled, non-replicate cross over comparative bioavailability study of single oral dose of 5mL of ARAMOX-600 (containing Amoxicillin 600mg/5ml) Suspension of Pathway Pharma, LLC and single oral dose of 7.5mL of Amoxicillin 400mg/5ml Suspension of Aurobindo Pharma in 12 healthy human adult subjects under fasting condition.
100 Clinical Results associated with Auriga Research Private Limited
0 Patents (Medical) associated with Auriga Research Private Limited
100 Deals associated with Auriga Research Private Limited
100 Translational Medicine associated with Auriga Research Private Limited